Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AFX 3772

Next Previous
Drug Profile

AFX 3772

Alternative Names: AFX-3772; ASP-3772; GSK-5101955; GSK-5101955A; GSK-5101956; GSK-5101956A; Pneumococcal 24-Valent -vaccine - Affinivax; Pneumococcal MAPS vaccine - Astellas Pharma/ Affinivax; Pneumococcal vaccine - Astellas Pharma; Streptococcus pneumoniae MAPS vaccine - Astellas Pharma

Latest Information Update: 22 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Affinivax
  • Class Bacterial vaccines; Conjugate vaccines; Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Pneumococcal infections

Most Recent Events

  • 31 Jul 2024 Phase-II clinical trials in Pneumococcal infections (In the elderly, Prevention, In adults) in USA (IM) (GSK pipeline, October 2024)
  • 28 Mar 2023 No recent reports of development identified for phase-I development in Pneumococcal-infections(In the elderly, Prevention, In adults) in Japan (IM, Injection)
  • 28 Mar 2023 No recent reports of development identified for phase-I development in Pneumococcal-infections(In the elderly, Prevention, In adults) in Japan (SC, Injection)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top